FILING ANALYSIS · WEDNESDAY, OCTOBER 14
MAXCYTE, INC. MXCT — 8-K: Results of Operations and Financial Condition
positive
MaxCyte, Inc. reported preliminary third quarter 2026 revenue of $8.1 million, a 26% increase from the same period in 2025, and raised its full-year 2026 revenue guidance to $34 million, driven by strong core business revenue and Strategic Platform License Program-related revenue.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →